Furthermore, SIRT6 is implicated in chemotherapy resistance and progression of breast cancer, and reduces the sensitivity of breast cancer to chemotherapeutic agents and then enhances cell proliferation and invasion 18, 19. Here, SIRT6 is linked to breast cancer.